FENG [Phoenix New Media] SC 13G/A: (Original Filing)

[(Name of Issuer) Class A Ordinary Shares (Title of Class of Securities) G7060L108 (CUSIP Number) April 30, 2015 (Date of Event Which Requires Filing of this Statement) [X] Rule 13d-1(b) [ ] Rule 13d-1(c) [ ] Rule 13d-1(d) * CUSIP No. G7060L108 1. NAMES OF REPORTING PERSONS 2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP 3. SEC]

CPHI [CHINA PHARMA] 10-Q: (Original Filing)

[FORM 10-Q (Mark One) x March 31, 2015 For the quarterly period ended o For the transition period from ____________ to ____________ CHINA PHARMA HOLDINGS, INC. Nevada 73-1564807 (State or other jurisdiction of (IRS Employer incorporation or organization) Identification No.) Second Floor, No. 17, Jinpan Road Haikou, Hainan Province, China 570216 +86- 898-6681-1730 (China) (Issuer's telephone number, including area code)] [CERTIFICATION OF OF THE SARBANES-OXLEY ACT OF 2002 I, Zhilin Li certify that: 1. I have reviewed this report on Form 10-Q of China Pharma Holdings, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of] [CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER OF THE SARBANES-OXLEY ACT OF 2002 I, Zhilin Li, certify that: 1. I have reviewed this report on Form 10-Q of China Pharma Holdings, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made,] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. Dated: May 11, 2015 President and Chief Executive Officer (principal financial officer and principal accounting officer) EX-32.1 4 cphi10qex321033115.htm]

By | 2016-03-28T19:18:36+00:00 May 11th, 2015|Categories: Chinese Stocks, CPHI, SEC Original|Tags: , , , , , |0 Comments

GURE [GULF RESOURCES] 8-K: (Original Filing)

[Gulf Resources Announced the Assessment Results of Natural Gas Resources Under Its Bromine Well in Sichuan SHOUGUANG, China, May 7, 2015 (GLOBE NEWSWIRE) -- Gulf Resources, Inc. (Nasdaq:GURE) ("Gulf Resources" or the "Company" or "GURE"), a leading manufacturer of bromine, crude salt and specialty chemical products in China, today announced the assessment results of natural gas resources under its bromine] [+86 (536) 567-0008 o o o o Item 8.01. Other Events. On May 7, 2015, Gulf Resources, Inc. (“Gulf Resources” or the “Company”), a leading manufacturer of bromine, crude salt and specialty chemical products in China, announced the assessment results of natural gas resources under its bromine well in Sichuan. According to the report, the major results of the study]

By | 2016-03-13T04:07:01+00:00 May 11th, 2015|Categories: Chinese Stocks, GURE, SEC Original|Tags: , , , , , |0 Comments

HGSH [CHINA HGS REAL ESTATE] 8-K: (Original Filing)

[China HGS Reports Second Quarter of Fiscal Year 2015 Results HANZHONG, CHINA May 11, 2015 Highlights for the Quarter l Total revenues for the second quarter of fiscal 2015 were approximately $23.6 million, a decrease of 53% from approximately $49.9 million in the same quarter of fiscal 2014. Total revenues recognized from percentage of completion method were approximately $20.9 million,] []

By | 2016-03-20T14:28:10+00:00 May 11th, 2015|Categories: Chinese Stocks, HGSH, SEC Original|Tags: , , , , , |0 Comments

KANG [iKang Healthcare] CORRESP: (Original Filing)

[May 11 , 2015 Ms. Sharon Blume Mr. Mark Brunhofer Mr. Jim B. Rosenberg Division of Corporation Finance 100F Street, NE Mail Stop 7010 U.S.A. Re: iKang Healthcare Group, Inc. Form 20-F for the Fiscal Year Ended March 31, 2014 Filed July 25, 2014 and Amended July 31, 2014 File No. 1-36403 Dear Ms. Sharon Blume, Mr. Mark Brunhofer and]

IMOS [CHIPMOS TECHNOLOGIES BERMUDA] 6-K: (Original Filing)

[ChipMOS TECHNOLOGIES (Bermuda) LTD. By S. J. Cheng Chairman & Chief Executive Officer Contacts: In Taiwan In the U.S. Dr. S.K. Chen David Pasquale ChipMOS TECHNOLOGIES (Bermuda) LTD. Global IR Partners +886-6-507-7712 +1-914-337-8801 s.k._chen@chipmos.com]

By | 2016-03-17T13:26:26+00:00 May 11th, 2015|Categories: Chinese Stocks, IMOS, SEC Original|Tags: , , , , , |0 Comments

KNDI [Kandi Technologies] 10-Q: (Original Filing)

[FORM 10-Q March 31, 2015 For the quarterly period ended or For the transition period from ______to______ 001-33997 KANDI TECHNOLOGIES GROUP, INC. Delaware 90-0363723 (State or other jurisdiction of (I.R.S. Employer Identification No.) incorporation or organization) Jinhua City Industrial Zone Jinhua, Zhejiang Province People’s Republic of China Post Code 321016 (86 - 579) 82239856 Large accelerated filer [ ] Accelerated] [SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002 I, Hu Xiaoming, certify that: 1. I have reviewed this report on Form 10-Q of Kandi Technologies Group, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of] [I, Wang Cheng (Henry), certify that: 1. I have reviewed this report on Form 10-Q of Kandi Technologies Group, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were] [18 U.S.C. § 1350, § 906 OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. (Principal Financial Officer and Principal Accounting Officer)]

Skip to toolbar